Optheras A/S
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Optheras A/S is a medical technology company that develops an innovative laser platform for the outpatient treatment of superficial bladder cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optheras A/S Comparables
Compare Optheras A/S with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vessi Medical | 81% | |
| CAPS Medical | 81% | |
| Combat Medical | 70% | |
Optheras A/S Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Seed | Aug 26, 2025 | ||||
| Angel | Jun 1, 2022 |
Optheras A/S Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| T&W Medical | Angel, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
Received grant funding from MedTech Innovator.
- Mar 9, 2026
Grew 20% QoQ, from 20 to 24 employees.
Optheras A/S Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Optheras A/S's valuation, stock price, and market status.